Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

Saved in:
Bibliographic Details
Title: Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
Authors: Smith MR (AUTHOR), McGovern FJ (AUTHOR), Zietman AL (AUTHOR), Fallon MA (AUTHOR), Hayden DL (AUTHOR), Schoenfeld DA (AUTHOR), Kantoff PW (AUTHOR), Finkelstein JS (AUTHOR)
Source: New England Journal of Medicine. 9/27/2001, Vol. 345 Issue 13, p948-955. 8p.
Database: Academic Search Ultimate
Description
ISSN:00284793